Ariad’s AP24534 in Publication (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that Cancer Cell, one of the leading scientific journals, has published a comprehensive paper describing the design and preclinical characterization of an investigational kinase inhibitor (AP24534).

Continue reading...

Keep Those Belts Tightened: The Job Market isn’t Getting Better

While there have been some signs of recovery in real estate and the stock market it seems that the job market is still declining. Online advertised vacancies declined by 83,200 to 3,280,000 in October, according to The Conference Board Help-Wanted OnLine Data Series (HWOL)(TM) released November 2. Of course those jobs are only representative of [...]

Continue reading...

Enzo Biochem NASH Results (NYSE:ENZ)

Enzo Biochem Inc. (NYSE:ENZ) announced today that they have favorable results of the Company’s clinical trial for the treatment of non-alcoholic steatohepatitis.

Continue reading...